A REVIEW OF LINK ALTERNATIF MBL77

Not all individuals with CLL demand therapy. Irrespective of all recent developments, the iwCLL nonetheless suggests watchful observation for patients with asymptomatic condition.86 This advice relies on at least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).Are